State-of-the-art progress on tamarind seed polysaccharide (Tamarindus indica) and its diverse potential applications, a review with insight
- PMID: 38388032
- DOI: 10.1016/j.carbpol.2024.121847
State-of-the-art progress on tamarind seed polysaccharide (Tamarindus indica) and its diverse potential applications, a review with insight
Abstract
Tamarind seed polysaccharide (TSP) is a biocompatible, non-ionic polymer with antioxidant properties. Its uses include drug delivery, food industry, and wastewater treatment. TSP has various hydroxy functional groups, one of the most favorable sites for graft copolymerization of different monomers. Hence, various chemical methods for TSP modification were developed to satisfy increasing industrial demand. Of particular interest in scientific community are the methods of graft copolymerization because of their ability to alter the physicochemical properties of TSP, including pH sensitivity and the swelling index, leading to improvements in the adsorption efficiency of hazardous heavy metals and dyes from wastewater effluents. Moreover, in recent years, TSP has been used for controlled drug delivery applications due to its unique advantages of high viscosity, broad pH tolerance, non-carcinogenicity, mucoadhesive properties, biocompatibility, and high drug entrapment capacity. In light of the plethora of literature on the topic, a comprehensive review of TSP-based graft copolymers and unmodified and modified TSP important applications is necessary. Therefore, this review comprehensively highlights several synthetic strategies for TSP-grafted copolymers and discusses unmodified and modified TSP potential applications, including cutting-edge pharmaceutical, environmental applications, etc. In brief, its many advantages make TSP-based polysaccharide a promising material for applications in various industries.
Keywords: Food packing applications; Graft copolymerization; Nanoparticles and complexes drug delivery; Tamarind seed polysaccharide; Toxic heavy metal/dye removal and wastewater treatment.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflicts of interest.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
